This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
WestRock Hits 52-Week High on Robust Capital Allocation
by Zacks Equity Research
WestRock (WRK) hit a 52-week high of $58.62 on Jul 10.
Greif (GEF) Poised to Grow, Slowdown in China Remains a Drag
by Zacks Equity Research
Greif (GEF) is poised to gain from benefit from sale of non-core assets and strong liquidity position.
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment
by Zacks Equity Research
Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Addus HomeCare, Luminex, Silgan Holdings and Two Harbors Investment
Avoid Market Volatility with 5 Low-Beta Stocks
by Zacks Equity Research
In this article, we present a strategy which proves that low risky securities can also reap rewards if some specific parameters are considered.
Here's Why Silgan Holdings (SLGN) Be in Your Portfolio Now
by Zacks Equity Research
In this write-up wwe highlight few points why Silgan Holdings, Inc. (SLGN) is a must-add to your portfolio right now.
Silgan (SLGN) Tops Q1 Earnings, Revenues, Lifts '17 EPS View
by Zacks Equity Research
Silgan's (SLGN) first-quarter 2017 earnings beat the Zacks Consensus Estimate.
WestRock (WRK) Beats on Q2 Earnings, Revenue Estimates
by Zacks Equity Research
WestRock Company's (WRK) second-quarter fiscal 2017 adjusted earnings and revenues beat the respective Zacks Consensus Estimate.
WestRock's (WRK) Q2 Earnings, Revenues Beat Estimates
by Zacks Equity Research
WestRock Company's (WRK) second quarter fiscal 2017 earnings and revenues beat the respective Zacks Consensus Estimates.
Silgan (SLGN) Buys WestRock's Dispensing Systems Business
by Zacks Equity Research
Silgan (SLGN) completed the acquisition of WestRock's dispensing systems business for $1.025 billion.
WestRock Sells Home, Health & Beauty Business to Silgan
by Zacks Equity Research
WestRock Company (WRK) has completed the sale of its Home, Health and Beauty business to Silgan Holdings Inc. (SLGN).
Silgan (SLGN) Scales 52-Week High on a Slew of Positives
by Zacks Equity Research
Silgan (SLGN) hit a 52-week high of $61.46 on Mar 20.
Silgan (SLGN) Q4 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Silgan Holdings Inc.'s (SLGN) Q4 adjusted earnings of 48 cents came in line with the Zacks Consensus Estimate while revenues lagged.
Silgan to Buy WestRock's Home, Health & Beauty Business
by Zacks Equity Research
Silgan (SLGN) has entered into a definitive agreement with WestRock to buy its Home, Health and Beauty unit for around $1 billion.
WestRock (WRK) Beats on Q1 Earnings, Bolsters Portfolio
by Zacks Equity Research
WestRock Company's (WRK) first-quarter fiscal 2017 adjusted earnings of 47 cents per share beat the Zacks Consensus Estimate.
WestRock's (WRK) Q1 Earnings Beats, Revenues Lag
by Zacks Equity Research
WestRock Company's (WRK) Q1 fiscal 2017 earnings beat the Zacks Consensus Estimate while revenues missed.